Tenshi Pharmaceuticals Private Limited, along with its promoter group, has increased its stake in Onesource Specialty Pharma Limited. The acquisition involved purchasing 85,000 equity shares, increasing their holding to 3,49,40,105 shares, which represents 30.48% of the total share/voting capital. The transaction, executed on February 4, 2026, was conducted via open market purchases.
Promoter Group’s Acquisition
Tenshi Pharmaceuticals Private Limited, acting in concert with its promoter group, has acquired an additional 85,000 equity shares of Onesource Specialty Pharma Limited. This acquisition increases their overall holding in the company.
Details of the Increased Holding
Prior to this acquisition, the promoter group held 3,48,55,105 shares, representing 30.41% of the total share/voting capital. Following the purchase of the additional shares, their total holding now stands at 3,49,40,105 shares, which accounts for 30.48% of the company’s total share/voting capital.
Transaction Details
The acquisition was executed through the open market on February 4, 2026. This transaction has resulted in a slight increase in the promoter group’s overall stake in Onesource Specialty Pharma Limited.
Share Capital Before and After Acquisition
The equity share capital and total voting capital of the company before and after the acquisition remained constant at 11,46,21,201 equity shares of Rs. 1 each, fully paid up.
Source: BSE
